Status: current, Defined. Date: 30-Jun 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1634921000168112 | selexipag 1.6 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1634931000168110 | selexipag 1.6 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| selexipag 1.6 mg tablet | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| selexipag 1.6 mg tablet | Is a | selexipag | true | Inferred relationship | Some | ||
| selexipag 1.6 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| selexipag 1.6 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 40228657 | |
| selexipag 1.6 mg tablet | has intended active ingredient | selexipag | true | Inferred relationship | Some | 40228656 | |
| selexipag 1.6 mg tablet | has Australian BoSS | selexipag | true | Inferred relationship | Some | 40228656 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Uptravi 1.6 mg tablet | Is a | True | selexipag 1.6 mg tablet | Inferred relationship | Some | |
| selexipag 1.6 mg tablet, 60 | has MPUU | True | selexipag 1.6 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR